(3D) Ultrasound Imaging Liver and Kidney
Recruiting now NCT03844399
Run by Western University, Canada · for 18 and older · All sexes
What this study is about
This study is to assess the addition of 3D ultrasound guidance during standard care ablation or biopsies of liver or kidney tumours. 3D ultrasound only differs from conventional 2D ultrasound in that the ultrasound transducer is mounted on a special assembly that moves the transducer in precise, stepped movements while a succession of 2D images are collected by the computer. Special software written specifically for 3D ultrasound precisely aligns these 2D images into a 3-demensional volume , allowing area in question to be viewed in many different planes. 3D ultrasound is a safe, fast, non-invasive imaging procedure. Ultrasound images will be checked against the pre- and post- procedure CT images to make sure the tumours were completely removed or properly targeted during biopsy.
Who can join (things the study team will check)
✅ You may be able to join if…
- • Patients who are scheduled for standard care liver or kidney ablation or biopsy
🚫 You may not be able to join if…
- None
Where this trial is running
- Victoria Hospital, London, Ontario, Canada
Who to contact
Aaron Fenster · 5199315777 · afenster@uwo.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT03844399.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.